149 related articles for article (PubMed ID: 38468826)
1. NG2 Molecule Expression in Acute Lymphoblastic Leukemia B Cells: A Flow-Cytometric Marker for the Rapid Identification of
Bisegna ML; Peragine N; Elia L; Matarazzo M; Milani ML; Intoppa S; Di Trani M; Malfona F; Martelli M; De Propris MS
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024018. PubMed ID: 38468826
[TBL] [Abstract][Full Text] [Related]
2. Quantification of NG2-positivity for the precise prediction of KMT2A gene rearrangements in childhood acute leukemia.
Zerkalenkova E; Mikhaylova E; Lebedeva S; Illarionova O; Baidun L; Kashpor S; Osipova E; Maschan M; Maschan A; Novichkova G; Olshanskaya Y; Popov A
Genes Chromosomes Cancer; 2021 Feb; 60(2):88-99. PubMed ID: 33135273
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric predictive scoring systems for common fusions ETV6/RUNX1, BCR/ABL1, TCF3/PBX1 and rearrangements of the KMT2A gene, proposed for the initial cytogenetic approach in cases of B-acute lymphoblastic leukemia.
Tsagarakis NJ; Papadhimitriou SI; Pavlidis D; Marinakis T; Kostopoulos IV; Stiakaki E; Polychronopoulou S; Paterakis G
Int J Lab Hematol; 2019 Jun; 41(3):364-372. PubMed ID: 30730614
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic portrait of leukemia-associated-phenotype markers in B acute lymphoblastic leukemia.
Boris E; Theron A; Montagnon V; Rouquier N; Almeras M; Moreaux J; Bret C
Cytometry B Clin Cytom; 2024 Jan; 106(1):45-57. PubMed ID: 38037221
[TBL] [Abstract][Full Text] [Related]
5. Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.
Kulis J; Sędek Ł; Słota Ł; Perkowski B; Szczepański T
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011285
[TBL] [Abstract][Full Text] [Related]
6. Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.
Schwartz S; Rieder H; Schläger B; Burmeister T; Fischer L; Thiel E
Leukemia; 2003 Aug; 17(8):1589-95. PubMed ID: 12886247
[TBL] [Abstract][Full Text] [Related]
7. Machine Learning Based Analysis of Relations between Antigen Expression and Genetic Aberrations in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia.
Kulis J; Wawrowski Ł; Sędek Ł; Wróbel Ł; Słota Ł; van der Velden VHJ; Szczepański T; Sikora M
J Clin Med; 2022 Apr; 11(9):. PubMed ID: 35566407
[TBL] [Abstract][Full Text] [Related]
8. Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children.
Gao C; Liu SG; Yue ZX; Liu Y; Liang J; Li J; Zhang YY; Yu JL; Wu Y; Lin W; Zheng HY; Zhang RD
Cancer Cell Int; 2019; 19():293. PubMed ID: 31807115
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic and prognostic features of TdT-negative pediatric B-lymphoblastic leukemia.
Klairmont MM; Zhou Y; Cheng C; Pui CH; Jeha S; Gruber TA; Liu Y; Inaba H; Choi JK
Mod Pathol; 2021 Nov; 34(11):2050-2054. PubMed ID: 34148065
[TBL] [Abstract][Full Text] [Related]
10. Updates in
Górecki M; Kozioł I; Kopystecka A; Budzyńska J; Zawitkowska J; Lejman M
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979800
[TBL] [Abstract][Full Text] [Related]
11. Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.
Wuchter C; Harbott J; Schoch C; Schnittger S; Borkhardt A; Karawajew L; Ratei R; Ruppert V; Haferlach T; Creutzig U; Dörken B; Ludwig WD
Leukemia; 2000 Jul; 14(7):1232-8. PubMed ID: 10914547
[TBL] [Abstract][Full Text] [Related]
12. MLL-rearranged B lymphoblastic leukemias selectively express the immunoregulatory carbohydrate-binding protein galectin-1.
Juszczynski P; Rodig SJ; Ouyang J; O'Donnell E; Takeyama K; Mlynarski W; Mycko K; Szczepanski T; Gaworczyk A; Krivtsov A; Faber J; Sinha AU; Rabinovich GA; Armstrong SA; Kutok JL; Shipp MA
Clin Cancer Res; 2010 Apr; 16(7):2122-30. PubMed ID: 20332322
[TBL] [Abstract][Full Text] [Related]
13. CD49f protein expression varies among genetic subgroups of B lymphoblastic leukemia and is distinctly low in KMT2A-rearranged cases.
Collins K; Cardinali JL; Mnayer LO; DiGiuseppe JA
Cytometry B Clin Cytom; 2021 Mar; 100(2):243-248. PubMed ID: 31894899
[TBL] [Abstract][Full Text] [Related]
14. Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements.
Behm FG; Smith FO; Raimondi SC; Pui CH; Bernstein ID
Blood; 1996 Feb; 87(3):1134-9. PubMed ID: 8562939
[TBL] [Abstract][Full Text] [Related]
15. MIC2, TdT, bcl-2, and CD34 expression in paraffin-embedded high-grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities.
Soslow RA; Bhargava V; Warnke RA
Hum Pathol; 1997 Oct; 28(10):1158-65. PubMed ID: 9343323
[TBL] [Abstract][Full Text] [Related]
16. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.
Smith FO; Rauch C; Williams DE; March CJ; Arthur D; Hilden J; Lampkin BC; Buckley JD; Buckley CV; Woods WG; Dinndorf PA; Sorensen P; Kersey J; Hammond D; Bernstein ID
Blood; 1996 Feb; 87(3):1123-33. PubMed ID: 8562938
[TBL] [Abstract][Full Text] [Related]
17. Therapy-induced Deletion in 11q23 Leading to Fusion of
Panagopoulos I; Andersen K; Eilert-Olsen M; Zeller B; Munthe-Kaas MC; Buechner J; Osnes LTN; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(1):67-81. PubMed ID: 33419897
[TBL] [Abstract][Full Text] [Related]
18. Hematological, clinical, immunophenotypic characterization, and treatment outcomes of prognostically significant genetic subtypes of B-lineage acute lymphoblastic leukemia: A report of 1021 patients from India.
Gupta DG; Varma N; Sharma P; Truica MI; Abdulkadir SA; Singh P; Singh Sachdeva MU; Naseem S; Siddiqui MR; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
Cancer; 2023 Nov; 129(21):3390-3404. PubMed ID: 37498973
[TBL] [Abstract][Full Text] [Related]
19. KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory.
Peterson JF; Baughn LB; Pearce KE; Williamson CM; Benevides Demasi JC; Olson RM; Goble TA; Meyer RG; Greipp PT; Ketterling RP
Genes Chromosomes Cancer; 2018 Nov; 57(11):541-546. PubMed ID: 30203571
[TBL] [Abstract][Full Text] [Related]
20. Lack of expression of the chondroitin sulphate proteoglycan neuron-glial antigen 2 on candidate stem cell populations in paediatric acute myeloid leukaemia/abn(11q23) and acute lymphoblastic leukaemia/t(4;11).
Neudenberger J; Hotfilder M; Rosemann A; Langebrake C; Reinhardt D; Pieters R; Schrauder A; Schrappe M; Röttgers S; Harbott J; Vormoor J
Br J Haematol; 2006 May; 133(3):337-44. PubMed ID: 16643437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
